Steris PLC (NYSE:STE) insider Michael J. Tokich sold 22,000 shares of the company’s stock in a transaction on Friday, June 21st. The shares were sold at an average price of $143.70, for a total transaction of $3,161,400.00. The transaction was disclosed in a document filed with the SEC, which is available at this link.
Shares of Steris stock traded down $2.24 during mid-day trading on Friday, reaching $147.98. 716,839 shares of the stock were exchanged, compared to its average volume of 497,545. The company has a market capitalization of $12.51 billion, a P/E ratio of 30.26 and a beta of 1.00. The company has a current ratio of 2.27, a quick ratio of 1.82 and a debt-to-equity ratio of 0.37. The company has a 50-day simple moving average of $142.73. Steris PLC has a fifty-two week low of $99.14 and a fifty-two week high of $154.09.
Steris (NYSE:STE) last announced its earnings results on Monday, May 13th. The medical equipment provider reported $1.53 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.44 by $0.09. The business had revenue of $768.00 million during the quarter, compared to analysts’ expectations of $738.87 million. Steris had a net margin of 10.93% and a return on equity of 13.34%. The firm’s revenue for the quarter was up 7.3% on a year-over-year basis. During the same quarter last year, the company posted $1.24 EPS. On average, equities research analysts expect that Steris PLC will post 5.37 EPS for the current fiscal year.
A number of hedge funds have recently made changes to their positions in the business. Evolution Wealth Advisors LLC bought a new position in shares of Steris in the second quarter valued at $27,000. Advisory Services Network LLC boosted its holdings in Steris by 26.0% in the fourth quarter. Advisory Services Network LLC now owns 427 shares of the medical equipment provider’s stock valued at $45,000 after acquiring an additional 88 shares during the last quarter. Executive Wealth Management LLC bought a new stake in Steris in the fourth quarter valued at approximately $47,000. CENTRAL TRUST Co boosted its holdings in Steris by 27.7% in the second quarter. CENTRAL TRUST Co now owns 590 shares of the medical equipment provider’s stock valued at $89,000 after acquiring an additional 128 shares during the last quarter. Finally, Icon Wealth Partners LLC bought a new stake in Steris in the first quarter valued at approximately $83,000. Hedge funds and other institutional investors own 83.38% of the company’s stock.
A number of equities analysts have recently issued reports on STE shares. Stephens restated a “hold” rating and issued a $17.00 price objective on shares of Capstar Financial in a research note on Wednesday, May 15th. JMP Securities increased their price objective on shares of Steris from $135.00 to $150.00 and gave the company a “market outperform” rating in a research note on Wednesday, May 22nd. Zacks Investment Research cut shares of German American Bancorp. from a “buy” rating to a “hold” rating in a research report on Tuesday, April 30th. Finally, KeyCorp increased their target price on shares of Steris from $135.00 to $138.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 15th. Five research analysts have rated the stock with a buy rating, The company presently has an average rating of “Buy” and an average price target of $148.20.
STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.
See Also: How is a price target determined?
Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.